Adenosine Triphosphate (ATP) Assays Market Report 2026

Adenosine Triphosphate (ATP) Assays Market Overview

• Adenosine Triphosphate (ATP) Assays market size has reached to $2.19 billion in 2025 • Expected to grow to $3.88 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Rising Disease Incidence Drives Growth In Adenosine Triphosphate (ATP) Assay Market • Market Trend: Major Companies Drive Efficiency With Kinase Testing Platforms In ATP Assay Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Adenosine Triphosphate (ATP) Assays Market?

Adenosine triphosphate (ATP) assays are analytical procedures for determining the concentrations of ATP in biological materials. ATP is an energy-carrying molecule found in all living creatures' cells that extracts chemical energy from the breakdown of food molecules and uses it to power other cellular operations. This assay monitors cellular energy state and function and is an essential tool in research, diagnostics, and medication discovery. The main types of adenosine triphosphate (ATP) assays are luminometric ATP assays, enzymatic ATP assays, bioluminescence resonance energy transfer (BRET) ATP assays, cell-based ATP assays, and others. Luminometric ATP assays refer to a type of ATP assay that utilize the principle of bioluminescence to measure the levels of adenosine triphosphate (ATP) in a sample and it is commonly used in research, drug discovery, and biomedical applications to assess cellular energy status, measure enzymatic activity, evaluate cell viability, and screen for ATP-modulating compounds. Major components are consumables and accessories, and instruments that are applied in drug discovery and development, clinical diagnostics, environmental testing, food safety and quality testing, and others. It is used in various end-users such as pharmaceutical and biotechnology companies, food and beverage industry, hospitals and diagnostics laboratories, and academic and research institutions.

What Is The Adenosine Triphosphate (ATP) Assays Market Growth Forecast?

The adenosine triphosphate (atp) assays market size is expected to see rapid growth in the next few years. It will grow to $3.88 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to development of high-throughput atp assay platforms, increasing integration with automated laboratory instruments, rising applications in clinical diagnostics and personalized medicine, expansion of biotechnology research and drug development, advancements in fluorescent and luminescent assay technologies. Major trends in the forecast period include increasing adoption of atp assays in drug discovery, rising use of cell-based assays for viability and cytotoxicity testing, expansion of atp assays in food safety and environmental testing, growing demand for luminometric and enzymatic atp assays, enhanced focus on assay sensitivity, accuracy, and standardization.

Global Adenosine Triphosphate (ATP) Assays Market Segmentation

1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types 2) By Component: Consumables And Accessories, Instruments 3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications 4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions Subsegments: 1) By Luminometric ATP Assays: Luciferase-Based Assays, Chemiluminescent Assays 2) By Enzymatic ATP Assays: Kinase-Based Assays, ATPase Activity Assays 3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions, BRET For Drug Discovery 4) By Cell-Based ATP Assays: Live-Cell ATP Measurement, Cell Viability Assays 5) By Other Types: Fluorescent ATP Assays, Spectrophotometric ATP Assays

What Are The Drivers Of The Adenosine Triphosphate (ATP) Assays Market?

The increasing frequency of cancer, chronic, and infectious diseases is expected to propel the growth of the adenosine triphosphate (ATP) assay market going forward. Cancer is characterized by uncontrolled cell growth, which can invade and damage surrounding tissues and potentially spread to other body parts. Chronic diseases are stable conditions that typically progress slowly and persist over an extended period. Infectious diseases are those caused by pathogenic microorganisms that can be spread from person to person, such as bacteria, viruses, fungi, or parasites. ATP assays provide a valuable tool in the diagnostics of these diseases by assessing cellular viability, detecting microbial contamination, evaluating treatment efficacy, and monitoring metabolic and mitochondrial dysfunction. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, It is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Moreover, in November 2024, according to the data published by the European Centre for Disease Prevention and Control (ECDC) Sweden-based European Union agency, a total of 112,883 HIV diagnoses were reported in 2023 across 47 out of 53 countries in the region, with 24,731 cases recorded in the European Union/European Economic Area (EU/EEA). The overall crude rate of HIV diagnoses reached 12.7 per 100,000 population, reflecting a 2.4% increase compared to the 12.4 per 100,000 rate observed in 2022. Therefore, the increasing frequency of cancer, chronic, and infectious diseases propels the adenosine triphosphate (ATP) assay industry. Rising demand for personalized treatment is expected to propel the growth of the adenosine triphosphate (ATP) assays market going forward. Personalized treatment refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's own genes or proteins. ATP assays can contribute to personalized approaches in infectious disease management. They can be employed to assess the effectiveness of antimicrobial agents against specific pathogens, aiding in the selection of the most appropriate and personalized treatment. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, which accounted for approximately 34% of all newly approved therapeutic molecular entities. Therefore, the growing demand for personalized medicine is driving the growth of the adenosine triphosphate (ATP) assays industry.

Key Players In The Global Adenosine Triphosphate (ATP) Assays Market

Major companies operating in the adenosine triphosphate (atp) assays market are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

Global Adenosine Triphosphate (ATP) Assays Market Trends and Insights

Major companies operating in the adenosine triphosphate (ATP) assays market are focused on developing technologically advanced kinase testing platforms to provide highly sensitive assays. A kinase testing platform is a specialized system used to evaluate kinase activity in biological samples, aiding drug discovery and development by delivering insights into kinase function and inhibition. For instance, in April 2024, Reaction Biology, a US-based biotechnology company, introduced the HotSpotTM ATP-Max KinomeScreen, which is an advanced assay designed for high-throughput kinase screening, featuring increased sensitivity that allows testing at 1 mM ATP levels. This innovative platform employs a gold standard filter binding radiometric assay to evaluate kinase activity across the largest array of kinase targets in the industry. By delivering physiologically relevant data, the HotSpotTM ATP-Max KinomeScreen empowers researchers to discover more potent and specific kinase inhibitors, enhancing drug discovery initiatives and facilitating the development of targeted therapies for a range of diseases, especially cancer.

Regional Outlook

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Adenosine Triphosphate (ATP) Assays Market?

The adenosine triphosphate (ATP) assays market consists of revenues earned by entities by providing testing services related to colorimetric and fluorescent assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The adenosine triphosphate (ATP) assays market also includes sales of luminometer, and chemiluminescent which are used in adenosine triphosphate (ATP) assay services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Adenosine Triphosphate (ATP) Assays Market Report 2026?

The adenosine triphosphate (atp) assays market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adenosine triphosphate (atp) assays industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.